Terry Livingston, PharmD, vice president of medical affairs at Octave Bioscience, discussed the evolving role of blood-based biomarkers in multiple sclerosis care.
Terrie Livingston, PharmD
Advertisement
Vice president of medical affairs at Octave Biosciences
Articles by Terrie Livingston, PharmD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Accepts Troriluzole NDA Resubmission for Spinocerebellar Ataxia
2
Remibrutinib Lowers Relapse Rate vs Teriflunomide in Relapsing MS
3
Tenecteplase Benefit Before Thrombectomy Varies by Stroke Cause, Study Shows
4
Calcium Channel Blockers Linked to Lower Blood Pressure Variability
5